Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...

Popoln opis

Bibliografske podrobnosti
Main Authors: Liang Yen Liu, Matthew S Ji, Nhung T Nguyen, Frances E Chow, Donna M Molaie, Sean T Pianka, Richard M Green, Linda M Liau, Benjamin M Ellingson, Phioanh L Nghiemphu, Timothy F Cloughesy, Albert Lai
Format: Article
Jezik:English
Izdano: Taylor & Francis Group 2019-06-01
Serija:CNS Oncology
Teme:
bevacizumab
glioblastoma
glioma
long term
progression
recurrence
Online dostop:https://www.futuremedicine.com/doi/10.2217/cns-2019-0007

Internet

https://www.futuremedicine.com/doi/10.2217/cns-2019-0007

Podobne knjige/članki